Immune mechanisms in arterial hypertension

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 677-686

  Wenzel, Ulrich ^a   Turner, Jan Eric ^a   Krebs, Christian ^a   Kurts, Christian ^b   Harrison, David G ^a   Ehmke, Heimo ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Division of Clinical Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; INFLAMMASOME; INTERLEUKIN 10; REACTIVE OXYGEN METABOLITE; CYTOKINE;

ADAPTIVE IMMUNITY; ARTERIAL STIFFNESS; BONE MARROW CELL; CD8+ T LYMPHOCYTE; COMPLEMENT ACTIVATION; DENDRITIC CELL; ENDOTHELIAL DYSFUNCTION; GRANULOCYTE; HOST CELL; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; JUXTAGLOMERULAR APPARATUS; MACROPHAGE; MICROBIOME; MONOCYTE; NONHUMAN; OLFACTORY RECEPTOR; PREHYPERTENSION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SODIUM URINE LEVEL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; VASCULAR REMODELING; VASCULAR RESISTANCE; ARTERIAL PRESSURE; COMPLICATION; IMMUNOLOGY; METABOLISM; MICROFLORA; NEPHRITIS;

ADAPTIVE IMMUNITY; ARTERIAL PRESSURE; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DENDRITIC CELLS; HUMANS; HYPERTENSION; IMMUNITY, INNATE; INFLAMMASOMES; MACROPHAGES; MICROBIOTA; MONOCYTES; NEPHRITIS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTE SUBSETS;

EID: 84959903923     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015050562     Document Type: Review

References (81)

1. Beilin LJ, Goldby FS,Mohring J: High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension. Clin SciMolMed 52: 111-117, 1977
2. Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, RincónJ,ChávezM,Parra G,Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ: Mycophenolate mofetil prevents saltsensitive hypertension resulting from angiotensin II exposure. Kidney Int 59: 2222-2232, 2001
3. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J ExpMed 204: 2449-2460, 2007
4. Crowley SD, Song YS, Lin EE, Griffiths R, Kim HS, Ruiz P: Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 298: R1089-R1097, 2010
5. Mattson DL, Lund H, Guo C, Rudemiller N, Geurts AM, Jacob H: Genetic mutation of recombination activating gene 1 in Dahl saltsensitive rats attenuates hypertension and renal damage. Am J Physiol Regul Integr Comp Physiol 304: R407-R414, 2013
6. Rudemiller N, Lund H, Jacob HJ, Geurts AM, Mattson DL; PhysGen Knockout Program: CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. Hypertension 63: 559-564, 2014
7. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension 57: 132-140, 2011
8. Zhang J, Crowley SD: Role of T lymphocytes in hypertension. Curr Opin Pharmacol 21: 14-19, 2015
9. Idris-Khodja N, Mian MO, Paradis P, Schiffrin EL: Dual opposing roles of adaptive immunity in hypertension. Eur Heart J 35: 1238-1244, 2014
10. McMaster WG, Kirabo A, Madhur MS, Harrison DG: Inflammation, immunity, and hypertensive end-organ damage. Circ Res 116: 1022-1033, 2015
11. Kolev M, Le FriecG, Kemper C: Complement-tapping into new sites and effector systems. Nat Rev Immunol 14: 811-820, 2014
12. Zhang C, Li Y, Wang C, Wu Y, CuiW,Miwa T, Sato S, Li H, Song WC, Du J: Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling. Arterioscler Thromb Vasc Biol 34: 1240-1248, 2014
13. Zhang C, Li Y, Wang C, Wu Y, Du J: Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension. Am J Hypertens 27: 857-864, 2014
14. Harrison DG: Basic science: Pathophysiology: Oxidative stress. J AmSoc Hypertens 8: 601-603, 2014
15. Montezano AC, Touyz RM: Reactive oxygen species, vascular Noxs, and hypertension: Focus on translational and clinical research. Antioxid Redox Signal 20: 164-182, 2014
16. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA,Weyand C, Gordon FJ, Harrison DG: Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin IIinduced hypertension. Circ Res 107: 263-270, 2010
17. Lob HE, Schultz D, Marvar PJ, Davisson RL, Harrison DG: Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension 61: 382-387, 2013
18. Carnevale D, Pallante F, Fardella V, Fardella S, Iacobucci R, FedericiM, Cifelli G, De Lucia M, Lembo G: The angiogenic factor PlGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension. Immunity 41: 737-752, 2014
19. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, Bikineyeva AT, Dikalov S, Xiao L, Chen W, Saleh MA, Trott DW, Itani HA, Vinh A, Amarnath V, Amarnath K, Guzik TJ, Bernstein KE, Shen XZ, Shyr Y, Chen SC, Mernaugh RL, Laffer CL, Elijovich F, Davies SS, Moreno H, Madhur MS, Roberts J 2nd, Harrison DG: DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest 124: 4642-4656, 2014
20. Liu J, Yang F, Yang XP, JankowskiM, Pagano PJ: NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 23: 776-782, 2003
21. Epelman S, Liu PP, Mann DL: Role of innate and adaptive immunemechanisms in cardiac injury and repair. Nat Rev Immunol 15: 117-129, 2015
22. Bomfim GF, Echem C, Martins CB, Costa TJ, Sartoretto SM, Dos Santos RA, Oliveira MA, Akamine EH, Fortes ZB, Tostes RC, Webb RC, Carvalho MH: Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats. Life Sci 122: 1-7, 2015
23. Eissler R, Schmaderer C, Rusai K, Kühne L, Sollinger D, Lahmer T, Witzke O, Lutz J, Heemann U, Baumann M: Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res 34: 551-558, 2011
24. Sollinger D, Eißler R, Lorenz S, Strand S, Chmielewski S, Aoqui C, Schmaderer C, Bluyssen H, Zicha J, Witzke O, Scherer E, Lutz J, Heemann U, Baumann M: Damageassociated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc Res 101: 464-472, 2014
25. McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T, Webb RC: Toll-like receptors and damage-associated molecular patterns: Novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 306: H184-H196, 2014
26. Harwani SC, Chapleau MW, Legge KL, Ballas ZK, Abboud FM: Neurohormonal modulation of the innate immune system is proinflammatory in the prehypertensive spontaneously hypertensive rat, a genetic model of essential hypertension. Circ Res 111: 1190-1197, 2012
27. Singh MV, Abboud FM: Toll-like receptors and hypertension. Am J Physiol Regul Integr Comp Physiol 307: R501-R504, 2014
28. Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR: IL-1b and IL-18: Inflammatory markers or mediators of hypertension? Br J Pharmacol 171: 5589-5602, 2014
29. Ji X, Naito Y, Weng H, Endo K, Ma X, Iwai N: P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension. Am J Physiol Renal Physiol 303: F1207-F1215, 2012
30. Wenzel P, KnorrM, Kossmann S, Stratmann J, HausDing M, Schuhmacher S, Karbach SH, Schwenk M, Yogev N, Schulz E, Oelze M, Grabbe S, Jonuleit H, Becker C, Daiber A, Waisman A, Münzel T: Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 124: 1370-1381, 2011
31. De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL: Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: Evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 25: 2106-2113, 2005
32. Ko EA, Amiri F, Pandey NR, Javeshghani D, Leibovitz E, Touyz RM, Schiffrin EL: Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: Evidence from m-CSF-deficient mice. Am J Physiol Heart Circ Physiol 292: H1789-H1795, 2007
33. Santisteban MM, Ahmari N, Carvajal JM, Zingler MB, Qi Y, Kim S, Joseph J, Garcia-Pereira F, Johnson RD, Shenoy V, Raizada MK, Zubcevic J: Involvement of bonemarrow cells and neuroinflammation in hypertension. Circ Res 117: 178-191, 2015
34. Saleh MA, McMaster WG, Wu J, Norlander AE, Funt SA, Thabet SR, Kirabo A, Xiao L, Chen W, Itani HA, Michell D, Huan T, Zhang Y, Takaki S, Titze J, Levy D, Harrison DG, Madhur MS: Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest 125: 1189-1202, 2015
35. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, YokoyamaWM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49, 2011
36. Eberl G, Di Santo JP, Vivier E: The brave new world of innate lymphoid cells. Nat Immunol 16: 1-5, 2015
37. Kossmann S, Schwenk M, HausDing M, Karbach SH, Schmidgen MI, Brandt M, Knorr M, Hu H, Kröller-Schön S, Schönfelder T, Grabbe S, Oelze M, Daiber A, Münzel T, Becker C, Wenzel P: Angiotensin II-induced vascular dysfunction depends on interferong-driven immune cell recruitment andmutual activation of monocytes and NK-cells. Arterioscler Thromb Vasc Biol 33: 1313-1319, 2013
38. McKenzie AN, Spits H, Eberl G: Innate lymphoid cells in inflammation and immunity. Immunity 41: 366-374, 2014
39. Zhou L: Striking similarity: GATA-3 regulates ILC2 and Th2 cells. Immunity 37: 589-591, 2012
40. Di Pietro C, Falcone M: The role of invariant NKT cells in organ-specific autoimmunity. Front Biosci (Landmark Ed) 19: 1240-1250, 2014
41. Ussher JE, Klenerman P, Willberg CB: Mucosal-associated invariant T-cells: New players in anti-bacterial immunity. Front Immunol 5: 450, 2014
42. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T: Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42: 31-38, 2003
43. Kamat NV, Thabet SR, Xiao L, Saleh MA, Kirabo A, Madhur MS, Delpire E, Harrison DG, McDonough AA: Renal transporter activation during angiotensin-II hypertension is blunted in interferon-g-/-and interleukin-17A-/-mice. Hypertension 65: 569-576, 2015
44. Zhang J, Patel MB, Griffiths R, Mao A, Song YS, Karlovich NS, Sparks MA, Jin H, Wu M, Lin EE, Crowley SD: Tumor necrosis factor-a produced in the kidney contributes to angiotensin II-dependent hypertension. Hypertension 64: 1275-1281, 2014
45. Markó L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ, Bowman EP, Kleinewietfeld M, Fokuhl V, Dechend R, Müller DN: Interferong signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 60: 1430-1436, 2012
46. van Heuven-Nolsen D, De Kimpe SJ, Muis T, van Ark I, Savelkoul H, Beems RB, van Oosterhout AJ,Nijkamp FP:Opposite role of interferon-gamma and interleukin-4 on the regulation of blood pressure in mice. Biochem Biophys Res Commun 254: 816-820, 1999
47. Li Y,Wu Y, Zhang C, Li P, CuiW, Hao J,Ma X, Yin Z, Du J: gdT Cell-derived interleukin-17A via an interleukin-1b-dependent mechanism mediates cardiac injury and fibrosis in hypertension. Hypertension 64: 305-314, 2014
48. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55: 500-507, 2010
49. Wu J, Thabet SR, Kirabo A, Trott DW, Saleh MA, Xiao L, Madhur MS, Chen W, Harrison DG: Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res 114: 616-625, 2014
50. Nguyen H, Chiasson VL, Chatterjee P, Kopriva SE, Young KJ, Mitchell BM: Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res 97: 696-704, 2013
51. Karbach S, Croxford AL, Oelze M, Schüler R, Minwegen D, Wegner J, Koukes L, Yogev N, Nikolaev A, Reißig S, Ullmann A, Knorr M, Waldner M, Neurath MF, Li H, Wu Z, Brochhausen C, Scheller J, Rose-John S, Piotrowski C, Bechmann I, Radsak M, Wild P, Daiber A, von Stebut E, Wenzel P, Waisman A, Münzel T: Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol 34: 2658-2668, 2014
52. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP: IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol 27: 2576-2581, 2007
53. Zhang W, Wang W, Yu H, Zhang Y, Dai Y, Ning C, Tao L, Sun H, Kellems RE, Blackburn MR, Xia Y: Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension 59: 136-144, 2012
54. Li K, Guo D, Zhu H, Hering-Smith KS, Hamm LL, Ouyang J, Dong Y: Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells. Am J Physiol Regul Integr Comp Physiol 299: R590-R595, 2010
55. Krebs CF, Lange S,NiemannG, Rosendahl A, Lehners A, Meyer-Schwesinger C, Stahl RA, Benndorf RA, Velden J, Paust HJ, Panzer U, Ehmke H, Wenzel UO: Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+ angiotensin ii-induced hypertension. Hypertension 63: 565-571, 2014
56. Mathur AN, Chang HC, Zisoulis DG, Kapur R, Belladonna ML, Kansas GS, Kaplan MH: T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 108: 1595-1601, 2006
57. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, Weaver CT: Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107, 2009
58. Kurschus FC, Croxford AL, Heinen AP, Wörtge S, Ielo D, Waisman A: Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol 40: 3336-3346, 2010
59. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, Ahlfors H,WilhelmC, TolainiM, Menzel U,GarefalakiA, Potocnik AJ, Stockinger B: Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12: 255-263, 2011
60. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA: Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496: 518-522, 2013
61. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, Regev A, Kuchroo VK: Induction of pathogenic TH17 cells by inducible saltsensing kinase SGK1. Nature 496: 513-517, 2013
62. Safa K,Ohori S, Borges TJ, UeharaM, Batal I, Shimizu T, Magee CN, Belizaire R, Abdi R, Wu C, Chandraker A, Riella LV: Salt accelerates allograft rejection through serum-and glucocorticoid-regulated kinase-1-dependent inhibition of regulatory T cells [published online ahead of print April 1, 2015]. J Am Soc Nephrol doi:10. 1681/ASN. 2014090914
63. Titze J, Machnik A: Sodium sensing in the interstitiumand relationship to hypertension. Curr Opin Nephrol Hypertens 19: 385-392, 2010
64. Jantsch J, Schatz V, Friedrich D, Schröder A, Kopp C, Siegert I, Maronna A, Wendelborn D, Linz P, Binger KJ, Gebhardt M, Heinig M, Neubert P, Fischer F, Teufel S, David JP, Neufert C, Cavallaro A, Rakova N, Küper C, Beck FX, NeuhoferW, Muller DN, Schuler G, Uder M, Bogdan C, Luft FC, Titze J: Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab 21: 493-501, 2015
65. Matrougui K, Abd Elmageed Z, KassanM,Choi S, Nair D, Gonzalez-Villalobos RA, Chentoufi AA, Kadowitz P, Belmadani S, Partyka M: Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol 178: 434-441, 2011
66. KvakanH, KleinewietfeldM,Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN: Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119: 2904-2912, 2009
67. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL: T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57: 469-476, 2011
68. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, Neves MF, Laurant P, Paradis P, Schiffrin EL: T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59: 324-330, 2012
69. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM: Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54: 619-624, 2009
70. Kassan M, Galan M, Partyka M, Trebak M, Matrougui K: Interleukin-10 released by CD4 (+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol 31: 2534-2542, 2011
71. Majeed B, Tawinwung S, Eberson LS, Secomb TW, Larmonier N, Larson DF: Interleukin-2/anti-interleukin-2 immune complex expands regulatory T cells and reduces angiotensin II-induced aortic stiffening. Int J Hypertens 2014: 126365, 2014
72. Chatterjee P, Chiasson VL, Seerangan G, Tobin RP, Kopriva SE, Newell-Rogers MK, Mitchell BM: Cotreatment with interleukin 4 and interleukin 10 modulates immune cells and prevents hypertension in pregnantmice. Am J Hypertens 28: 135-142, 2015
73. Trott DW, Thabet SR, Kirabo A, Saleh MA, Itani H, Norlander AE, Wu J, Goldstein A, Arendshorst WJ, Madhur MS, Chen W, Li CI, Shyr Y, Harrison DG: Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension 64: 1108-1115, 2014
74. Weisheit CK, Engel DR, Kurts C: Dendritic cells and macrophages: Sentinels in the kidney [published online ahead of print January 7, 2015]. Clin J Am Soc Nephrol doi: 10. 2215/CJN. 07100714
75. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ: Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122: 2529-2537, 2010
76. SuranaNK, Kasper DL:Decipheringthe tête-àtête between the microbiota and the immune system. JClin Invest 124: 4197-4203, 2014
77. TangWH, Hazen SL: The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 124: 4204-4211, 2014
78. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J,Caplan MJ: Olfactory receptor responDing to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A 110: 4410-4415, 2013
79. Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, Haribabu B, Vijay-Kumar M, Pennathur S, Joe B: Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics 47: 187-197, 2015
80. Freedman BI, Sedor JR: Hypertensionassociated kidney disease: Perhaps no more. J Am Soc Nephrol 19: 2047-2051, 2008
81. Anders HJ, Baumann M, Tripepi G, Mallamaci F: Immunity in arterial hypertension: Associations or causalities? [Published online ahead of print March 11, 2015] Nephrol Dial Transplant doi: 10. 1093/ndt/ gfv057